* Medifast Inc MED.N MED is expected to show a fall in
quarterly revenue when it reports results on February 20 for
the period ending December 31 2023
* The Owings Mills Maryland-based company is expected to
report a
45.4% decrease in revenue to $184.15 million from $337.25
million a year ago, according to the mean estimate from 2
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Medifast Inc is for
earnings
of 96 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Medifast
Inc is
$62.50, above its last closing price of $49.99.
This summary was machine generated February 16 at 22:41 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)